Transcripts Sumitomo Pharma Co., Ltd.

Equities

4506

JP3495000006

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-17 am EDT			5-day change	1st Jan Change
336 ^JPY	-5.35%		-17.44%	-27.90%

May. 09	Sumitomo Pharma Co., Ltd. agreed to acquire MELTz Business of MELTIN MMI Co., Ltd.	CI
May. 07	Profit-Taking, China Outlooks Churn Asian Stock Markets	MT

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Sumitomo Pharma Co., Ltd., Q3 2024 Earnings Call, Jan 31, 2024	Jan. 31
Transcript : Sumitomo Pharma Co., Ltd., Q1 2024 Earnings Call, Jul 31, 2023	23-07-31
Transcript : Sumitomo Pharma Co., Ltd., 2023 Earnings Call, May 15, 2023	23-05-15
Transcript : Sumitomo Pharma Co., Ltd. - Shareholder/Analyst Call	23-04-28
Transcript : Sumitomo Pharma Co., Ltd., Q3 2023 Earnings Call, Jan 31, 2023	23-01-31
Transcript : Sumitomo Pharma Co., Ltd. - Special Call	22-12-12
Transcript : Sumitomo Pharma Co., Ltd., Q2 2023 Earnings Call, Nov 01, 2022	22-10-31
Transcript : Sumitomo Pharma Co., Ltd., Q1 2023 Earnings Call, Jul 29, 2022	22-07-29
Sumitomo Pharma Co., Ltd. Provides Earnings Guidance for the Year Ending March 31, 2023	22-07-29	CI
Transcript : Sumitomo Dainippon Pharma Co., Ltd., 2022 Earnings Call, May 16, 2022	22-05-15
Sumitomo Dainippon Pharma Co., Ltd. Provides Financial Guidance for the Year Ending March 31, 2023	22-05-13	CI
Transcript : Sumitomo Dainippon Pharma Co., Ltd., Q3 2022 Earnings Call, Jan 31, 2022	22-01-31
Sumitomo Dainippon Pharma Co., Ltd. Provides Financial Guidance for the Year Ending March 31, 2022	22-01-31	CI
Transcript : Sumitomo Dainippon Pharma Co., Ltd. - Special Call	21-12-08
Transcript : Sumitomo Dainippon Pharma Co., Ltd., Q2 2022 Earnings Call, Oct 28, 2021	21-10-27
Sumitomo Dainippon Pharma Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2022	21-10-27	CI
Transcript : Sumitomo Dainippon Pharma Co., Ltd. - Analyst/Investor Day	21-09-08
Sumitomo Dainippon Pharma Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2022	21-07-29	CI
Transcript : Sumitomo Dainippon Pharma Co., Ltd., Q1 2022 Earnings Call, Jul 29, 2021	21-07-28
Transcript : Sumitomo Dainippon Pharma Co., Ltd., Q4 2021 Earnings Call, May 13, 2021	21-05-13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Transcripts Sumitomo Pharma Co., Ltd.

Equities

4506

JP3495000006

Transcripts

Filters